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Abstract. Human antigen R (HuR) is a post-translational 
modifier of mRNAs rich in AU- and U-rich elements. These 
mRNAs typically code for proteins involved in cell growth 
and differentiation, signal transduction, transcriptional and 
translational control, apoptosis, nutrient transport and metabo-
lism. Thus, HuR affects a variety of biological functions and 
processes. Via its effect on growth and cellular migration, HuR 
has been shown to enhance clinical progression of a number 
of cancers. Its role in wound healing remains unknown. In the 
present study, we evaluated HuR tissue expression in a cohort 
of chronic healed and non-healed leg ulcers. We also evalu-
ated the effect of HuR knockdown on a number of cellular 
processes using the HaCaT human keratinocyte cell line. HuR 
was expressed in greater levels in the ‘chronic healed’ cohort 
of ulcers, compared to the ‘chronic non-healed’, although this 
failed to reach statistical significance (p=0.13). HuR knock-
down resulted in greater cellular growth, faster progression 
through the cell cycle and reduced apoptosis. Furthermore, it 
reduced cellular adhesion rates without affecting migration. 
We, therefore, concluded that HuR promotes wound healing, 
primarily through its effect on cellular adhesion. It also slows 
cellular growth rate via its effect on both cell cycle progression 
and rates of apoptosis.
Introduction
Human antigen R (HuR) was first cloned and identified as 
a member of the Hu family in 1996 (1); it was localised to 
chromosome 19 a year later (2). The Hu family is composed of 
the neuronal Hu proteins HuB, HuC and HuD, as well as the 
ubiquitously expressed protein HuR (2). The three neuronal 
Hu proteins, only expressed in differentiated neurons, play 
important roles in neuronal plasticity and differentiation. In 
humans, HuR is widely expressed in all proliferating cells. 
The Hu protein family shares homology with the Drosophila 
embryonic lethal abnormal vision (ELAV) proteins, and are 
thus occasionally referred to as the Hu/ELAV family (3). 
The HuR protein contains three RNA recognition motifs 
(RRMs 1-3) which share a >90% amino acid sequence identity 
with other Hu family members (4). RRM1 and 2 bind to the 
AU- and U-rich elements (also known as AREs) of mRNA, 
while RRM3 is thought to bind to the poly A tail and promote 
stability of the protein/mRNA complex (5-7). HuR also 
contains a variable basic hinge region between RRM2 and 
RRM3, which contains the HuR nucleo-cytoplasmic shuttling 
sequence (HNS). This sequence allows HuR to shuttle mRNA 
between the nucleus and cytoplasm (8). It is this ability of HuR 
to transport mRNAs rich in AREs, and thus alter their expres-
sion, which allows it to affect a number of biological functions. 
Many ARE-rich mRNAs encode functionally diverse proteins, 
including proteins regulating cell growth and differentiation, 
signal transduction, transcriptional and translational control, 
haematopoiesis, apoptosis, nutrient transport and metabolism 
(9). A number of these functions contribute to carcinogenesis, 
and elevated HuR levels have been associated with a poorer 
prognosis in colonic (10), breast (11), ovarian (12,13) and 
gastric carcinoma (14) (reviewed in ref. 15).
Wound healing is a complex co-ordinated response to 
injury, which is divided into four overlapping phases: haemo-
stasis, inflammation, proliferation and maturation (16). Failure 
or prolongation of one or more phases results in either healing 
delay or non-closure of the wound. Chronic wounds present a 
serious problem to both the patient and the physician – they are 
a source of much morbidity and even mortality, they are costly 
to treat and can be difficult to manage (17). The dynamic 
cellular events during the process of wound healing requires 
co-ordinated gene and protein expression at a time- and 
location-dependent manner. Thus, regulation of mRNA, the 
key function of HuR, during the healing process is essential. 
HuR has not been previously studied in the context of wound 
healing. In this study, we firstly analysed HuR transcript levels 
in wound tissues, and, secondly, we evaluated the effects of 
HuR knockdown on cellular functions using the human kerati-
nocyte ‘HaCaT’ cell line.
Materials and methods
Cells and tissues. The HaCaT human keratinocyte cell line was 
purchased from the German Cancer Institute. These cells were 
routinely cultured in DMEM/Ham's F12 with L-glutamine 
medium (PAA Laboratories, Somerset, UK), supplemented 
with streptomycin, penicillin and 10% foetal calf serum 
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(PAA Laboratories), and incubated at 37˚C in 5% CO2 and 
95% humidity. Human wound tissues were collected from 
patients who attended wound clinics at the University Hospital 
of Wales, with the approval of the South East Wales Local 
Research Ethics Committee. Core biopsies were taken from 
the wound edge, and were immediately stored at -80˚C and 
subsequently in liquid nitrogen, until used. The wound tissues 
were all chronic (present for a minimum of 3 months despite 
conservative treatment) and of venous ulcer aetiology. They 
were biopsied at the time of the visit to the clinic (time zero), 
after which patients were treated and followed up routinely. 
Wounds that healed within 3 months of their initial visit were 
classified as ‘Chronic healed’, whereas those which failed to 
heal within the time frame were termed ‘Chronic non-healed’. 
The samples were anonymised before processing and only 
decoded after the final test. Our wound tissue cohort comprised 
51 chronic non-healing wounds and 20 chronic healed wounds.
Total cellular RNA preparation. Total cellular RNA was 
isolated from the homogenized tissue samples and human cell 
lines using the TRI reagent (Sigma, Dorset, UK), according 
to the manufacturer's protocol. Following extraction, the 
RNA concentration was quantified through spectrophoto-
metric measurement (WPA UV 1101; Biotech Photometer, 
Cambridge, UK).
Reverse transcription-polymerase chain reaction (RT-PCR). 
cDNA was generated from 250 ng of each RNA sample and 
reverse transcription was undertaken using an enhanced avian 
RT-PCR-100 kit with anchored oligo(dt) primers (Sigma). 
The quality of cDNA was verified using primers to detect 
the housekeeping gene GAPDH (full primer sequences are 
outlined in Table I). Conventional PCR was performed in a 
T-Cy Thermocycler (Creacon Technologies Ltd., CD Emmen, 
The Netherlands) using REDTaq® ReadyMix™ PCR Reaction 
Mix (Sigma).
PCR conditions were as follows: denaturing at 94˚C for 
30 sec, annealing at 55˚C for 30 sec and extension at 72˚C 
for 30 sec. PCR was conducted over 38 cycles with an initial 
5-min denaturing step (94˚C) and a final 10-min extension step 
(72˚C), and stored until required at 4˚C. The PCR products 
were then loaded into a 0.8% agarose gel, separated electro-
phoretically, stained with ethidium bromide and visualised 
under ultraviolet light.
Quantitative-polymerase chain reaction (Q-PCR). The iCycler 
IQ system (Bio-Rad, Hertfordshire, UK) was used to detect 
and quantify the number of HuR transcripts in the wound 
specimens (18), as previously described (19,20). The results 
are provided as copy number/µl based on an internal standard. 
The results were further normalised against the expression 
of GAPDH in these samples. The Q-PCR technique used the 
Amplifluor system (Intergen Inc., Purchase, NY, USA), Q-PCR 
Master Mix (ABgene, Surrey, UK) and a universal probe 
(Uniprimer™; Intergen) to record the fluorescence emitted by 
the z-sequences. Conditions for Q-PCR were an initial period 
of 15 min at 95˚C, followed by 80 cycles of 95˚C for 15 sec, 
55˚C for 60 sec and 72˚C for 20 sec. Full details of the primers 
used are outlined in Table I.
Generation of HuR knockdown in human keratinocyte cell 
lines. Anti-human HuR hammerhead ribozymes were designed 
based on the secondary structure of HuR mRNA, generated 
using the Zuker RNA mFold program (21). The ribozymes 
were synthesized and cloned into a pEF6/V5-His-TOPO 
plasmid vector (Invitrogen, Paisley, UK). An appropriate 
ribozyme transgene and empty pEF6 control plasmid were 
transfected into HaCaT cells, as previously reported (22,23). 
Following transfection and blasticidin selection, cells were 
subsequently cultured in maintenance medium and routinely 
tested to confirm knockdown of HuR expression. HaCaT cells 
containing the ribozyme transgenes and the control PEF plas-
mids were designated as HaCaT HuR knockdown and HaCaT 
PEF, respectively. 
SDS-PAGE and Western blotting. Following lysis of cells, 
equal amounts of protein from each sample were separated on 
a 10% acrylamide gel. Proteins were probed using the respec-
tive primary antibodies at a concentration of 1:300 (HuR) 
and 1:500 (GAPDH) and specific peroxidase-conjugated 
secondary antibodies at a concentration of 1:1,000. Protein 
bands were documented using a gel documentation system 
(UVITech, Cambridge, UK).
In vitro growth assay. Cells (3,000) from the HuR knockdown 
and PEF control cell line were seeded into a 96-well plate in 
triplicate. Cells were then incubated for 1, 3 and 5 days before 
being fixed in 4% formaldehyde (v/v) and stained with 0.5% 
(w/v) crystal violet. The crystal violet stain was then extracted 
using 10% acetic acid (v/v) and cell density was determined 
by measuring the absorbance of this solution at a wavelength 
of 540 nm using an EL x800 spectrophotometer (Bio-Tek 
Instruments Inc., Winooski, VT, USA). Data was normalised 
using day 1 absorbance to account for any seeding bias.
Analysis of cell cycle. Cells (500,000) were seeded into a 
large flask (75 cm2) in normal medium on day 0. On day 1, 
the normal medium was replaced with serum-free medium to 
Table I. Primer sequences for conventional and quantitative PCR.
 Sense primers (5'-3') Antisense primers (5'-3')
HuR (PCR) GAGCTCAGAGGTGATCAAAG TTGTAGATGAAAATGCACCA
HuR (Q-PCR) AGACATGTTCTCTCGGTTTG ACTGAACCTGACCGTACAACTGGTAATTGCCTCTTCTG
GAPDH (PCR) GGCTGCTTTTAACTCTGGTA GACTGTGGTCATGAGTCCTT
GAPDH (Q-PCR) CTGAGTACGTCGTGGAGTC ACTGAACCTGACCGTACACAGAGATGATGACCCTTTTG
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arrest cellular proliferation in the G0 phase. On the evening 
of day 3, the medium was changed back to normal to restart 
cellular proliferation. Sixteen hours later, the cells were 
collected, fixed in 70% ethanol at 4˚C for 2 h, resuspended in 
1 ml of PI staining solution, and incubated for 15 min at 37˚C. 
The samples were then analysed using the Partec CyFlow® 
SL flow cytometer and the accompanied FloMax software 
package (Partec GmbH, Munich, Germany). The cell cycle 
was determined using DNA content to label cells in either the 
G0/1, S or G2/M phase of replication.
Analysis of apoptosis. Cells (150,000 or 300,000) were seeded 
into 25-cm2 flasks labelled normal or serum-free medium, 
respectively, and initially filled with normal medium. On 
day 1 the medium was changed in all flasks to either normal or 
serum-free, as appropriate. On day 4, all cells were harvested, 
including the cells floating in the culture medium, and resus-
pended in 1X Annexin-binding buffer at a concentration of 
~1x106 cells/ml. FITC annexin V (5 µl) and 1 µl of the PI 
working solution (100 µg/ml, supplied by Vybrant®) was added 
to each 100 µl of cell suspension, and the cells were incubated 
at 37˚C for 15 min. Annexin binding buffer 1X (400 µl) was 
then added prior to processing, which was performed using 
the Partec CyFlow® SL flow cytometer and the accompanied 
FloMax software package (Partec GmbH).
Electric cell-substrate impedance sensing (ECIS) adhesion 
and motility assay. The ECIS 1600R model instrument and 
8W10 arrays (Applied Biophysics, Inc., Troy, NJ, USA) were 
used, as previously described (24). Following treatment of the 
surface with a cysteine solution, the arrays were incubated 
with complete medium for 1 h. The same number of HaCaT 
cells (40,000) was added to each well. After reaching conflu-
ence, the cells were subject to wounding using the integrated 
elevated field module in the instrument in the 1600R model 
(5 V, 30 sec). Changes in cellular impedance were recorded 
during initial attachment and following wounding at 4,000 Hz. 
Statistical analysis. Experimental procedures were repeated 
independently a minimum of three times. Data were analysed 
using the Minitab 14 software, and statistical comparisons 
were drawn using the two-sample, two-tailed t-test or the 
Mann-Whitney non-parametric test as appropriate. P<0.05 
was considered to denote statistical significance.
Results
Expression levels of HuR transcripts in wound tissues. We 
firstly wanted to ascertain the expression of HuR in various 
tissue samples. Using a quantitative approach, we analysed the 
level of the HuR transcript in wound tissues using RT Q-PCR. 
Median levels of the HuR transcript were higher in healed 
chronic wounds [median (IQR): 0.044 (0-0.16)], compared to 
non-healed chronic wounds [median (IQR): 0 (0-1.0); Fig. 1], 
although this failed to reach statistical significance (P=0.13, 
Mann Whitney U-test).
Knockdown of HuR expression in HaCaT cells. In order to 
further evaluate HuR function in vitro, we screened the human 
keratinocyte cell line for presence of HuR. After confirming 
that HuR was expressed in the HaCaT cells, we created a 
HaCaT HuR knockdown cell line and the control HaCaT PEF 
cell line (empty plasmid control) using stable transfection, as 
described above. After 2 weeks of cell culture in selection 
medium, mRNA was extracted from both cell lines. Standard 
PCR confirmed a reduction in HuR mRNA level in the HuR 
knockdown cell line compared to the PEF cell line, and subse-
quent Western blotting confirmed that HuR expression was 
also reduced at the protein level (Fig. 2).
Effect of HuR knockdown on growth, cell cycle and apoptosis. 
HuR has been shown to alter growth rates in cancer cell lines 
(25). After confirmation of knockdown, we analysed growth 
using a standard 5-day growth assay. When normalised to data 
from day 1, HuR knockdown cells demonstrated a consistently 
faster rate of growth when compared to the PEF cell line 
(P<0.0001; Fig. 3A).
In order to further clarify the mechanism via which HuR 
has its effect on growth, we analysed the effect of HuR knock-
down on cell cycle and apoptosis. Cell cycle was analysed 
using the Partec CyFlow® SL flow cytometer. HuR knock-
down resulted in a greater portion of cells progressing to the S 
and G2/M phase, compared to the PEF control (Fig. 3B). This 
would be consistent with the increased growth rate observed in 
the HuR knockdown cell line.
Figure 1. Levels of HuR mRNA transcript in chronic healed (n=20), and 
chronic non-healed (n=51) ulcers, normalised to GAPDH (values shown are 
medians). HuR expression was non-significantly higher in the healed chronic 
wounds [median (IQR): 0.044 (0-0.16)], compared to the non-healed wounds 
[median (IQR): 0 (0-1.0), P=0.13].
Figure 2. Creation of HuR knockdown keratinocytes. (A) Knockdown of 
HuR mRNA confirmed on standard PCR. (B) Knockdown of HuR confirmed 
with Western blotting. HuR Kd, HuR knockdown.
  A   B
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We also analysed the effect of HuR knockdown on apop-
tosis. When cultured under normal conditions, HuR knockdown 
had minimal effect on apoptosis (Fig. 3C). When cultured 
in serum-free medium, HuR knockdown resulted in reduced 
levels of apoptosis, with a corresponding increase in live cells 
(Fig. 3D). Again, this would be consistent with the increased 
growth rate observed in the HuR knockdown cell line.
Analysis of adhesion and migration. We analysed the effect of 
HuR knockdown on both adhesion and migration using ECIS. 
Once cells were seeded, the internal resistance of each well 
was measured at regular intervals. As cells adhere to the elec-
trode, resistance increases. We analysed normalised resistance 
at 4 h, as shown in Fig. 3. This demonstrated a significantly 
reduced rate of adhesion of the HuR knockdown cell line 
(P=0.02; Fig. 3E).
After the resistance for each well had plateaued, typically 
after 6-8 h, the monolayer was wounded using the integrated 
elevated field module. We found that the optimum wound is 
created using 5 V for 30 sec for each well. Following wounding, 
the resistance reaches its nadir, which is subsequently recorded 
as time zero, and against which all subsequent readings are 
normalised. We found that knockdown of HuR had no signifi-
cant effect on rates of migration when compared to the PEF 
control (P=0.16; Fig. 3F). 
Discussion
Successful wound healing requires the coordination of a 
number of processes to ensure timely closure of a wound. In 
recent years, greater attention has been given to molecular 
changes within keratinocytes on the edge of chronic wounds. 
Figure 3. Effects of HuR knockdown on the biological functions of HaCaT and PEF cell lines (labelled HuR and PEF). (A) Growth assay normalised to day 1 
to account for seeding bias. Results shown are the means of 3 repeats ± SEM. There was no effect on growth rates on day 3, but by day 5 there was significantly 
faster growth noted in the HuR knockdown cells compared to the PEF control (P<0.0001, two-tailed t-test). (B) Analysis of cell cycle. Results from each cell 
line total 100%. HuR knockdown resulted in a greater proportion of cells reaching G2/M phase, when compared to PEF. (C and D) Analysis of apoptosis with 
cells cultured in (C) normal medium and (D) serum-free medium. Results from each cell line total 100%. HuR knockdown had minimal effect on apoptosis 
when cultured in normal medium, but showed a reduction in apoptosis in serum-free medium. This corresponds with an increase in the number of live cells. 
As expected, necrosis is far more common in serum-free conditions compared to normal medium. (E) Analysis of adhesion at 4 h post-seeding. Results shown 
are the means of a minimum of 4 runs ± SEM, and normalised to the intrinsic resistance within the ECIS machinery. HuR knockdown reduced adhesion 
significantly at 4 h (P=0.02). (F) Analysis of post-wounding migration measured at 4 h. Results shown are the means of a minimum of 4 runs ± SEM, and 
normalised to the intrinsic resistance within the ECIS machinery. HuR knockdown had no significant effect on HaCaT migration.
  A   B
  C   D
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Certain authors have explored variations in gene expression at 
the wound edge using microarray technology, searching for 
distinctive gene signatures and molecular patterns found in the 
keratinocytes bordering healing and non-healing wounds. For 
example, Cole et al (26) analysed the expression of mRNA in 
normal and acutely wounded skin from healthy volunteers at 
30 and 60 min after wounding. They found that 124 (3%) out 
of the 4,000 genes investigated (primarily involved in tran-
scription and signalling) demonstrated a significant increase 
from baseline (2 times) at 30 min (with no genes significantly 
down-regulated). At 60 min, 46 (1.15%) out of the 4,000 genes 
were significantly overexpressed, but 264 (6.6%) out of the 
4,000 genes (a number of which have unknown functions) were 
down-regulated. These findings help delineate the molecular 
changes occurring in the acute response to wounding. Other 
authors have used similar methods to evaluate the gene signa-
tures of healing and non-healing wounds (27).
We recently investigated the effects of individual genes 
on wound healing using both in vitro and in vivo data. For 
example, Ehm2 (expressed in highly metastatic cells 2) was 
found to be up-regulated in acute wounds compared to chronic 
wounds. Further in vitro analysis showed that Ehm2 promotes 
HaCaT motility, without affecting growth rates (28). Analysis 
of individual genes allows for a greater understanding of the 
molecular mechanisms behind the abnormal cellular behav-
iour noted in chronic wounds, and allows for identification of 
potential treatment targets.
HuR is a well-known post-transcriptional regulator of 
mRNAs rich in AREs (15). By shuttling these inherently 
unstable mRNAs from the nucleus to the cytoplasm, HuR 
affects a number of key cellular processes. Target mRNAs 
include the cell cycle regulators c-myc (29), cyclin A and B1 
(30) and cyclin E1 (31), as well as angiogenic promoters and 
proto-oncogenes (15).
HuR has been extensively evaluated in cancer. Elevated 
levels have been associated with a poorer prognosis in a number 
of neoplastic processes, including colonic (10), breast (11), 
ovarian (12,13) and gastric carcinoma (14). HuR expression 
appears to enhance the progression of cancer by up-regulating 
cellular proliferation, angiogenesis, invasion and migration 
(15). It is well-known that cancer and wound healing share 
a number of similar cellular changes, albeit occurring in an 
uncoordinated fashion in cancer (32,33). We thus hypothesised 
that HuR would be up-regulated in healing wounds.
Our study is the first to investigate HuR with regards to 
wound healing using the HaCaT keratinocyte cell line. We 
showed that, as predicted, HuR expression was higher in chronic 
healed wounds compared to chronic non-healed wounds, 
although this failed to reach statistical significance. HuR knock-
down increased growth in the HaCaT cell line, implying that 
elevated HuR levels reduce cellular growth. Furthermore, we 
demonstrated that this increased growth rate was due to more 
rapid progression through the cell cycle in the knockdown 
cell line, and a partial reduction in rates of apoptosis. When 
HuR expression is reduced in cancerous cell lines, growth is 
typically inhibited, as is cell cycle progression (25,30). Thus, 
HuR knockdown results in markedly differing behaviour in 
the non-malignant HaCaT cell line compared to cancerous cell 
lines. Our research group has found similar differences between 
malignant and non-malignant cell lines with other proteins. 
For example, Ehm2 knockdown was found to inhibit growth in 
MCF-7 breast cancer cells by increasing apoptosis (34), whereas 
a similar knockdown in HaCaT cells had no effect on either 
growth or apoptosis (28). These data highlight the importance 
of caution when assuming that wound healing pathways func-
tion in an identical manner to cancerous pathways.
HuR knockdown reduces cellular adhesion, with minimal 
affect on migration. HuR thus functions as a pro-adhesive 
protein in the HaCaT cell line. Re-epithelialisation is char-
acterized by epithelial migration, in which the adhesion of 
epithelial cells to the ECM plays a prominent role (35,36). It 
is most likely that this effect on adhesion is the mechanism 
through which HuR promotes wound healing. 
In conclusion, this is the first study to specifically analyse 
HuR in the context of wound healing. Elevated HuR levels 
are associated with a non-significant trend towards increased 
healing in vivo. We used a stably transfected HuR knockdown 
cell line to further evaluate the role of HuR in wound healing. 
In vitro data suggest that HuR reduces cellular growth, slows 
cell cycle progression and increases apoptosis. Furthermore, 
HuR improves cellular adhesion, a possible mechanism 
through which it enhances wound healing. 
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